BUFFALO, NY — Two experts from Roswell Park Cancer Institute (RPCI) will respond to questions in an upcoming CancerConnect Web Chat on the topic Treatment Options for Patients with Liver Cancer. Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, Co-Directors of RPCI’s Liver and Pancreas Tumor Center, will give a presentation on different approaches to treating liver cancer beginning at 6 pm EDT Tuesday, March 20, after which they’ll share information in a 30-minute Q&A session.
Both recognized experts in pancreatic and liver cancers, Drs. Kuvshinoff and Iyer are actively involved in clinical care and research, leading innovative studies on liver cancer and other gastrointestinal cancers.
Each year in the United States, more than 28,000 people are diagnosed with primary liver cancer. Although long-term survival with liver cancer remains poor, advances in surgery, other liver-directed therapies, and targeted systemic therapies are all contributing to improved outcomes. In addition, advances in supportive care have made liver cancer treatment more tolerable, leading to improved quality of life. Understanding treatment options and how and when to access new and innovative treatment options available through clinical trials is essential for achieving the best outcomes from liver cancer treatment.
Go to http://cancerconnect.com/md-boris-kuvshinoff/ to submit a question to be answered by Drs. Kuvshinoff and Iyer during the live Web Chat. The experts hope to respond to all submitted questions during the 30-minute live Q&A portion of the program.
CancerConnect, operated by OMNI Health Media, is a comprehensive online resource that provides information and support for cancer patients, their loved ones and their caregivers. Access the Roswell Park CancerConnect community at www.cancerconnect.com/roswellpark.
The Live Web Chat is not intended to be a substitute for healthcare professional medical advice, diagnosis, or treatment. Speak to your healthcare provider about any questions you may have regarding your health.
The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. RPCI, founded in 1898, was one of the first cancer centers in the country to be named a National Cancer Institute-designated comprehensive cancer center and remains the only facility with this designation in Upstate New York. The Institute is a member of the prestigious National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers; maintains affiliate sites; and is a partner in national and international collaborative programs. For more information, visit RPCI’s website at http://www.roswellpark.org, call 1-877-ASK-RPCI (1-877-275-7724) or email firstname.lastname@example.org.